Targeting Tyro3 ameliorates a model of PGRN-mutant FTLD-TDP via tau-mediated synaptic pathology.
Fujita K, Chen X, Homma H, Tagawa K, Amano M, Saito A, Imoto S, Akatsu H, Hashizume Y, Kaibuchi K, Miyano S, Okazawa H.
Fujita K, et al. Among authors: imoto s.
Nat Commun. 2018 Jan 30;9(1):433. doi: 10.1038/s41467-018-02821-z.
Nat Commun. 2018.
PMID: 29382817
Free PMC article.